Radiol med (2017) 122:676–682 DOI 10.1007/s11547-017-0768-0 NEURORADIOLOGY Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results 1 1 1 1 Alba Fiorentino · Niccolò Giaj‑Levra · Umberto Tebano · Rosario Mazzola · 1 1 2 1 Francesco Ricchetti · Sergio Fersino · Gioacchino Di Paola · Dario Aiello · 1 1 Ruggero Ruggieri · Filippo Alongi Received: 4 November 2016 / Accepted: 12 April 2017 / Published online: 26 April 2017 © Italian Society of Medical Radiology 2017 Abstract follow-up time of 12 months (range 1–27 months), the Aim For selected patients with brain metastases (BMs), median overall survival was 14 months and the 6-month the role of stereotactic radiosurgery (SRS) or fractionated overall survival was 77%. Finally, the median intracranial stereotactic radiotherapy (SFRT) is well recognized. The disease control was 11 months. Acute and late toxicities recent introduction of flattening filter free (FFF) delivery were acceptable without severe events (no adverse events during linac-based SRS or SFRT allows shorter beam-on- ≥G2 were recorded). time, improving patients’ comfort and facility workflow. Conclusions These preliminary results highlighted the Nevertheless, limited experiences evaluated the impact of feasibility and
La radiologia medica – Springer Journals
Published: Apr 26, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud